General Information |
|
Product |
Syncytin 1 Peptide |
Verified Applications |
Immunodepletion, Immunocompetition |
Peptide Description |
Synthetic peptide taken within amino acid region 480-538 on human Syncytin-1 protein. |
|
|
Quantity |
250 µg |
Volume |
100 µl |
Form |
Antigenic Blocking Peptide |
Storage |
-20⁰C for long term storage |
|
|
Competition/Depletion assay |
|
|
|
Uniprot # |
|
Overview |
This endogenous retroviral envelope protein has retained its original fusogenic properties and participates in trophoblast fusion and the formation of a syncytium during placenta morphogenesis. May induce fusion through binding of SLC1A4 and SLC1A5 (PubMed:10708449, PubMed:12050356, PubMed:23492904).3 Publications Endogenous envelope proteins may have kept, lost or modified their original function during evolution. |
Molecular Function |
Anatomical structure morphogenesis, syncytium formation |
Subcellular Location |
Cell membrane |
Expression |
Expressed at higher level in placental syncytiotrophoblast. Expressed at intermediate level in testis. Seems also to be found at low level in adrenal tissue, bone marrow, breast, colon, kidney, ovary, prostate, skin, spleen, thymus, thyroid, brain and trachea. Both mRNA and protein levels are significantly increased in the brain of individuals with multiple sclerosis, particularly in astrocytes and microglia. |
Structure |
The cytoplasmic region is essential for the fusiogenic function. The 17 amino acids long immunosuppressive region is present in many retroviral envelope proteins. Synthetic peptides derived from this relatively conserved sequence inhibit immune function in vitro and in vivo. |
Alternative Nomenclature |
Endogenous retrovirus group W member 1 antibody |
Protein information supplied by UniProt
Product | Note | Status | Price | |
---|---|---|---|---|
|
SYCY1-112AP | |||
|
SYCY1-112-BIOTIN | |||
|
SYCY1-112-FITC | |||
|
PC-SYCY1 | |||
Display accessory details |
Select your currency:
(c) FabGennix International Inc.